| Study Name | Eligibility |
| AstraZeneca JASMINE (AZ) | Individuals 18-75 years old diagnosed with probably or definite dermatomyositis or polymyositis with moderate to severe disease activity. |
| AstraZeneca LaunchPAD-RA (AZ, MO) | Individuals 18 years or older with moderate to severe active Rheumatoid Arthritis. |
| AstraZeneca SUNFLOWER (AZ/MD/MO) | Adults 18 to 70 years old diagnosed with systemic lupus erythematosus (SLE) who have received only antimalarial or glucocorticoid treatment. |
| Aurinia PRESERVE: LUPYKINIS (MO, PA, MD) | Adults 18-75 years old with biopsy proven lupus nephritis receiving belimumab, anifrolumab or obinutuzumab |
| Axsome (AZ) | Adults 18 years old or older with a primary diagnosis of fibromyalgia |
| BMS Benchmark-SLE (IL/MD/TX/TN) | Individuals aged 16+ years old diagnosed with SLE and/or Lupus nephritis |
| BMS IM011-1271 | Adults aged 18-65 with psoriatic arthritis that remains active despite TNFi treatment |
| Crystalys 201 (AZ, MD) | Adults 18-75 years old with gout who're unable to use allopurinol/febuxostat |
| Crystalys 301 (AZ) | Adults 18 to 75 years old, diagnosed with active gout on stable medications |
| Crystalys 302 (AZ) | Adults aged 18 to 75 years old diagnosed with gout with at least 1 tophus, currently treated with allopurinol. |
| Cullinan SLE T Cell Study (AZ) | This study is with a novel T-Cell Engager. We are recruiting Lupus patients in the Phoenix & Tucson Area. |
| Dermatomyositis and Polymyositis | This study is for patients with Active Dermatomyositis and Polymyositis. If you are experiencing symptoms of these diseases, you may be eligible for this trial. Learn more today! |
| Elevara START SYNERGY (AZ) | Adults 18-75 years old with active rheumatoid arthritis and a BMI between 18.5 and 32 kg/m2 |
| Merck 13 (AZ, MO, TX, MD, IL, TN) | Adults 18-80 years old with Radiographic Ankylosing Spondylitis |
| Merck 15 (AZ, MD, MO) | Adults 18 - 80 years old with active PsA and plaque psoriasis |
| NephroNet Synergy (AZ, TX) | Adults age 18 to 80 years old with SLE and lupus nephritis currently taking Belimumab (Benlysta) or planning to start. |
| Novartis CDDY391B12201 (AZ, PA, MD, VA) | Adults aged 18 years or older diagnosed with Sjogren's disease |
| OctaPharma NGAM-16 (AZ, TX) | adults 18 years or older with a rheumatic or autoimmune condition & hypogammaglobulinemia (low IgG levels) |
| Olatec OLT1177-08 Gout - Arizona | This study is for a new medication for active gout flares. If you are experience frequent gout flares, you may be eligible for this study. This study is in Glendale and Mesa, AZ. |
| Priovant Alpine (TN) | Adults age 18 years or older with active Lichen planopilaris (LPP) |
| Roche WA45846 (AZ) | Adults 18 years or older with rheumatoid arthritis who's had an inadequate response or intolerance to TNF and/or JAK inhibitors |
| Sanofi Polymyalgia Rheumatica (AZ, TX, MD, TN, PA) | Adults 50 years of age or older with newly diagnosed polymyalgia rheumatica |
| Takeda TAK-279-PsA-3001 (AZ) | Adults 18 years old or older with active PsA |
| UCB SL0044 (AZ/ IL/ MD/ MO/ TX) | Individuals 16 years of age or older with moderate to severe SLE |
| VorBio (AZ, MD, IL,PA) | Adults 18 to 75 years of age diagnosed with primary Sjogren's Syndrome |